POLYMYXIN B SULFATE

POLYMYXIN B SULFATE was reported 1860 times

POLYMYXIN B SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALPHA 1 FOETOPROTEIN AMNIOTIC FLUID DECREASED 1 1.0000
1 HEPATIC HYPOPERFUSION 1 0.1429
2 VAGINAL FLATULENCE 33 0.1089
3 NASAL OEDEMA 191 0.1056
4 CONJUNCTIVAL RETRACTION 1 0.0625
5 RESPIRATORY PARALYSIS 9 0.0563
6 BARREL CHEST 1 0.0526
7 LARYNGEAL TREMOR 1 0.0476
8 GRAFT VERSUS HOST DISEASE IN INTESTINE 5 0.0385
9 ENDOTOXAEMIA 1 0.0385
10 FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0323
11 CEMENTOPLASTY 1 0.0312
12 INTESTINAL HYPOMOTILITY 1 0.0294
13 BACILLUS BACTERAEMIA 3 0.0275
14 DISSEMINATED SPOROTRICHOSIS 1 0.0263
15 CHOLANGITIS INFECTIVE 7 0.0263
16 HEPATIC VEIN OCCLUSION 4 0.0253
17 SUPERINFECTION FUNGAL 2 0.0235
18 FLAVOBACTERIUM INFECTION 1 0.0227
19 CAROTID PULSE DECREASED 1 0.0222
20 TRICHOSPORON INFECTION 9 0.0222
21 LEUKAEMIC INFILTRATION PULMONARY 1 0.0217
22 EWING'S SARCOMA 1 0.0217
23 ENGRAFT FAILURE 6 0.0209
24 FEMALE GENITAL TRACT FISTULA 34 0.0199
25 PSEUDO-BARTTER SYNDROME 2 0.0192
26 MESENTERIC LYMPHADENITIS 1 0.0192
27 INFECTION PROTOZOAL 1 0.0175
28 RETINOIC ACID SYNDROME 3 0.0174
29 POST PROCEDURAL OEDEMA 4 0.0172
30 CEREBRAL MICROINFARCTION 1 0.0172
31 ENGRAFTMENT SYNDROME 10 0.0169
32 AEROMONAS INFECTION 3 0.0159
33 CAPILLARY PERMEABILITY INCREASED 1 0.0154
34 HEPATIC AMOEBIASIS 1 0.0149
35 MACULAR DEGENERATION 176 0.0147
36 PTERYGIUM 5 0.0145
37 BACTERIAL CULTURE POSITIVE 1 0.0141
38 CYTOMEGALOVIRUS MUCOCUTANEOUS ULCER 1 0.0139
39 NEUROMUSCULAR BLOCKADE 3 0.0134
40 CEREBRAL VENTRICLE COLLAPSE 1 0.0133
41 BACTERIAL TRANSLOCATION 4 0.0126
42 PERIPHERAL VEIN THROMBOSIS 3 0.0126
43 RADICULOPATHY 33 0.0125
44 DYSBIOSIS 10 0.0122
45 HYPOPHARYNGEAL CANCER 1 0.0119
46 CYTOMEGALOVIRUS TEST POSITIVE 21 0.0118
47 PROCTITIS 33 0.0118
48 FOETAL HEART RATE INCREASED 1 0.0114
49 HERPES SIMPLEX MENINGOENCEPHALITIS 1 0.0112
50 CHRONIC SINUSITIS 41 0.0109
51 HUMAN BOCAVIRUS INFECTION 2 0.0106
52 CREATINE PHOSPHOKINASE DECREASED 1 0.0105
53 FOETAL MOVEMENTS DECREASED 1 0.0098
54 BAND NEUTROPHIL PERCENTAGE INCREASED 1 0.0096
55 ABDOMINAL COMPARTMENT SYNDROME 6 0.0094
56 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 2 0.0089
57 CONJUNCTIVAL EROSION 1 0.0083
58 BRACHIOCEPHALIC VEIN THROMBOSIS 1 0.0081
59 CHEST WALL MASS 2 0.0077
60 MUCOUS MEMBRANE DISORDER 10 0.0073
61 ENTEROCOLITIS BACTERIAL 2 0.0072
62 TRAUMATIC HAEMOTHORAX 2 0.0072
63 RESPIRATORY TRACT INFECTION 187 0.0072
64 CSF CELL COUNT INCREASED 1 0.0068
65 FIBRIN DEGRADATION PRODUCTS INCREASED 2 0.0068
66 DIAPHRAGMATIC PARALYSIS 4 0.0067
67 ASPERGILLUS TEST POSITIVE 2 0.0065
68 BACILLUS INFECTION 4 0.0063
69 CYTOMEGALOVIRUS ANTIBODY POSITIVE 1 0.0063
70 CENTRAL NERVOUS SYSTEM NEOPLASM 1 0.0062
71 GRAFT VERSUS HOST DISEASE IN LIVER 4 0.0056
72 CRYPTOGENIC ORGANISING PNEUMONIA 1 0.0054
73 ACCELERATED HYPERTENSION 2 0.0053
74 CYSTITIS VIRAL 2 0.0052
75 CHOROIDAL HAEMORRHAGE 1 0.0052
76 EYE INFECTION FUNGAL 2 0.0052
77 GENITAL TRACT INFLAMMATION 1 0.0050
78 DEPENDENCE ON RESPIRATOR 2 0.0050
79 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 4 0.0049
80 BACTERIAL DIARRHOEA 1 0.0047
81 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 13 0.0047
82 DISSEMINATED CYTOMEGALOVIRAL INFECTION 1 0.0046
83 KLEBSIELLA TEST POSITIVE 3 0.0046
84 ACINETOBACTER INFECTION 5 0.0046
85 IRON BINDING CAPACITY TOTAL DECREASED 1 0.0045
86 DRUG CLEARANCE INCREASED 1 0.0045
87 ILIOTIBIAL BAND SYNDROME 1 0.0044
88 BLOOD FIBRINOGEN DECREASED 5 0.0044
89 FOETAL HEART RATE DECELERATION 1 0.0043
90 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 1 0.0043
91 SJS-TEN OVERLAP 3 0.0043
92 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 6 0.0042
93 EXTRAVASATION BLOOD 1 0.0042
94 CHRONIC GRAFT VERSUS HOST DISEASE 15 0.0042
95 ENCEPHALITIS HERPES 2 0.0040
96 PNEUMOMEDIASTINUM 7 0.0039
97 OEDEMA 208 0.0038
98 BACTEROIDES INFECTION 1 0.0038
99 HERPES ZOSTER REACTIVATION 1 0.0038
100 HERPES ZOSTER DISSEMINATED 3 0.0037
101 HYPERAMYLASAEMIA 2 0.0037
102 ANTITHROMBIN III DECREASED 1 0.0037
103 BLOOD CHOLINESTERASE DECREASED 1 0.0036
104 SEPTIC EMBOLUS 3 0.0036
105 PATHOGEN RESISTANCE 32 0.0035
106 EYE INFECTION STAPHYLOCOCCAL 1 0.0035
107 HYPERTENSIVE ENCEPHALOPATHY 2 0.0034
108 KNEE DEFORMITY 5 0.0034
109 CARDIAC FUNCTION TEST ABNORMAL 1 0.0034
110 URINARY TRACT INFECTION PSEUDOMONAL 2 0.0033
111 ELECTROCARDIOGRAM QT SHORTENED 1 0.0033
112 VAGINAL DISCHARGE 33 0.0033
113 HEPATIC ISCHAEMIA 1 0.0032
114 PARAESTHESIA ORAL 46 0.0032
115 GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0032
116 ASPERGILLOMA 1 0.0031
117 HAEMATOLOGY TEST ABNORMAL 1 0.0031
118 CELLULITE 1 0.0031
119 WHEEZING 181 0.0030
120 CAROTID ARTERY ANEURYSM 1 0.0029
121 VIRAL HAEMORRHAGIC CYSTITIS 2 0.0028
122 KLEBSIELLA INFECTION 14 0.0028
123 ORAL CANDIDIASIS 36 0.0027
124 CENTRAL LINE INFECTION 1 0.0027
125 KLEBSIELLA SEPSIS 3 0.0027
126 INSTILLATION SITE PRURITUS 1 0.0027
127 HYDROURETER 1 0.0026
128 COAGULATION TEST ABNORMAL 2 0.0026
129 CYTOMEGALOVIRUS ENTEROCOLITIS 2 0.0026
130 ADMINISTRATION SITE REACTION 1 0.0026
131 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 2 0.0025
132 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 1 0.0025
133 LYMPHOCYTIC LEUKAEMIA 1 0.0025
134 OTITIS EXTERNA 3 0.0025
135 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 2 0.0024
136 FUNGAL SEPSIS 2 0.0024
137 ACUTE GRAFT VERSUS HOST DISEASE 11 0.0024
138 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
139 MUSCLE STRENGTH ABNORMAL 1 0.0024
140 JOINT SURGERY 1 0.0023
141 EYELID INFECTION 1 0.0023
142 CARDIAC OUTPUT DECREASED 2 0.0023
143 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 4 0.0023
144 PSEUDOMEMBRANOUS COLITIS 5 0.0022
145 CORNEAL ABRASION 3 0.0022
146 VASOSPASM 2 0.0022
147 PNEUMONIA KLEBSIELLA 4 0.0022
148 DYSPHASIA 1 0.0021
149 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
150 GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0021
151 BLOOD BICARBONATE INCREASED 1 0.0021
152 BONE MARROW DEPRESSION 2 0.0020
153 ARTERIOVENOUS FISTULA 1 0.0020
154 HYPERSPLENISM 1 0.0020
155 GENITAL ERYTHEMA 1 0.0020
156 MUSCLE HAEMORRHAGE 8 0.0020
157 DISSEMINATED INTRAVASCULAR COAGULATION 28 0.0020
158 BLAST CELL COUNT INCREASED 2 0.0019
159 GASTRIC ANTRAL VASCULAR ECTASIA 1 0.0019
160 ANAL STENOSIS 1 0.0019
161 INADEQUATE DIET 1 0.0019
162 CORYNEBACTERIUM INFECTION 1 0.0019
163 ASTHMA 207 0.0018
164 MILK ALLERGY 1 0.0018
165 CYTOMEGALOVIRUS VIRAEMIA 8 0.0018
166 VANISHING BILE DUCT SYNDROME 2 0.0018
167 RENAL TUBULAR DISORDER 5 0.0018
168 APNOEIC ATTACK 1 0.0018
169 PSEUDOMONAL SEPSIS 3 0.0017
170 GRAFT COMPLICATION 1 0.0017
171 RENAL TUBULAR INJURY 2 0.0016
172 DRUG RESISTANCE 42 0.0016
173 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
174 MONOCYTOSIS 1 0.0016
175 LEUKOENCEPHALOPATHY 6 0.0016
176 VENOOCCLUSIVE DISEASE 4 0.0016
177 NECROTISING COLITIS 2 0.0016
178 PNEUMONIA CYTOMEGALOVIRAL 3 0.0015
179 GASTROINTESTINAL MUCOSAL DISORDER 1 0.0015
180 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 5 0.0015
181 SKIN HYPERPIGMENTATION 13 0.0015
182 EMBOLIC CEREBRAL INFARCTION 1 0.0015
183 HYPOPLASTIC LEFT HEART SYNDROME 1 0.0015
184 EYELID PAIN 3 0.0015
185 STENOTROPHOMONAS INFECTION 2 0.0015
186 INFECTIOUS PERITONITIS 1 0.0015
187 CYTOKINE STORM 1 0.0015
188 WOUND COMPLICATION 5 0.0015
189 NEUTROPENIC COLITIS 3 0.0014
190 ENTEROCOCCAL INFECTION 7 0.0014
191 PROCEDURAL PAIN 40 0.0014
192 EPSTEIN-BARR VIRUS INFECTION 9 0.0014
193 GLASSY EYES 1 0.0014
194 MONOCYTE PERCENTAGE INCREASED 1 0.0014
195 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
196 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
197 ANTIBODY TEST ABNORMAL 1 0.0014
198 GASTRIC MUCOSAL LESION 1 0.0014
199 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
200 MYASTHENIA GRAVIS CRISIS 2 0.0013
201 CHOLESTATIC LIVER INJURY 3 0.0013
202 HISTIOCYTOSIS HAEMATOPHAGIC 4 0.0013
203 ARTERIAL INJURY 1 0.0013
204 HEART SOUNDS ABNORMAL 1 0.0013
205 ARTERIAL RUPTURE 1 0.0013
206 OSTEOMALACIA 2 0.0013
207 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
208 INFECTION PARASITIC 1 0.0013
209 FREQUENT BOWEL MOVEMENTS 34 0.0013
210 GRAFT VERSUS HOST DISEASE 9 0.0013
211 LYMPHOCYTE STIMULATION TEST POSITIVE 1 0.0012
212 METABOLIC ALKALOSIS 2 0.0012
213 HAPTOGLOBIN DECREASED 1 0.0012
214 THROMBOTIC MICROANGIOPATHY 12 0.0012
215 LUNG OPERATION 1 0.0012
216 BLOOD PH DECREASED 2 0.0012
217 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3 0.0012
218 BLOOD CHLORIDE INCREASED 2 0.0012
219 RETINITIS 2 0.0012
220 NECROTISING FASCIITIS 4 0.0011
221 JUGULAR VEIN THROMBOSIS 2 0.0011
222 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 1 0.0011
223 DRUG DETOXIFICATION 1 0.0011
224 HYPERLACTACIDAEMIA 3 0.0011
225 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
226 CHEST PAIN 202 0.0011
227 LOBAR PNEUMONIA 2 0.0011
228 C-REACTIVE PROTEIN 1 0.0011
229 HEPATIC FUNCTION ABNORMAL 40 0.0011
230 NEPHROPATHY TOXIC 12 0.0011
231 PROTEIN TOTAL DECREASED 4 0.0011
232 BRAIN STEM HAEMORRHAGE 1 0.0011
233 DELAYED RECOVERY FROM ANAESTHESIA 1 0.0011
234 HYPOPROTEINAEMIA 2 0.0011
235 KLEBSIELLA BACTERAEMIA 1 0.0011
236 BLOOD URINE 1 0.0010
237 COARCTATION OF THE AORTA 1 0.0010
238 ADENOVIRUS INFECTION 3 0.0010
239 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
240 CYTOMEGALOVIRUS INFECTION 17 0.0010
241 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
242 HAEMOPHILUS INFECTION 1 0.0010
243 DUODENAL PERFORATION 1 0.0010
244 VENOOCCLUSIVE LIVER DISEASE 5 0.0010
245 GENE MUTATION 2 0.0010
246 EMPYEMA 2 0.0010
247 CYSTITIS HAEMORRHAGIC 4 0.0010
248 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 5 0.0010
249 CORONAVIRUS TEST POSITIVE 1 0.0010
250 CAROTID ARTERIOSCLEROSIS 1 0.0010
251 CAPILLARY LEAK SYNDROME 2 0.0010
252 MULTIPLE-DRUG RESISTANCE 3 0.0010
253 VARICELLA ZOSTER VIRUS INFECTION 2 0.0010
254 HEART TRANSPLANT REJECTION 1 0.0010
255 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
256 IRIDOCYCLITIS 3 0.0009
257 BONE DEMINERALISATION 1 0.0009
258 BLOOD SODIUM ABNORMAL 1 0.0009
259 RADIATION PNEUMONITIS 2 0.0009
260 PSEUDOMONAS INFECTION 8 0.0009
261 ACUTE MYELOID LEUKAEMIA RECURRENT 2 0.0009
262 COLITIS 35 0.0009
263 BACTERIAL SEPSIS 3 0.0009
264 INSTILLATION SITE REACTION 1 0.0009
265 NEUROTOXICITY 16 0.0009
266 CLOSTRIDIUM TEST POSITIVE 2 0.0009
267 HYPOALBUMINAEMIA 7 0.0009
268 SUSPECTED OFF LABEL USE 4 0.0009
269 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
270 PNEUMONIA BACTERIAL 8 0.0009
271 CARBON DIOXIDE DECREASED 1 0.0009
272 LUMBAR RADICULOPATHY 1 0.0009
273 BILIRUBIN CONJUGATED INCREASED 2 0.0009
274 CONJUNCTIVAL HYPERAEMIA 3 0.0008
275 EYELID SKIN DRYNESS 1 0.0008
276 CLOSTRIDIUM COLITIS 1 0.0008
277 FEBRILE CONVULSION 1 0.0008
278 STAPHYLOCOCCAL SEPSIS 4 0.0008
279 HYPERPARATHYROIDISM SECONDARY 2 0.0008
280 SYSTEMIC CANDIDA 2 0.0008
281 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
282 RECTAL HAEMORRHAGE 34 0.0008
283 URINARY TRACT INFECTION BACTERIAL 2 0.0008
284 GLUCOSE URINE PRESENT 1 0.0008
285 PNEUMONIA 254 0.0008
286 IATROGENIC INJURY 1 0.0008
287 ACQUIRED GENE MUTATION 1 0.0008
288 COLITIS ULCERATIVE 34 0.0008
289 BLOOD ALBUMIN DECREASED 6 0.0008
290 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
291 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
292 GLYCOSURIA 1 0.0007
293 ACUTE RESPIRATORY DISTRESS SYNDROME 13 0.0007
294 CARBON DIOXIDE INCREASED 1 0.0007
295 EFFUSION 1 0.0007
296 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
297 ABSCESS ORAL 1 0.0007
298 INFUSION RELATED REACTION 47 0.0007
299 HYPERPYREXIA 3 0.0007
300 MENINGITIS BACTERIAL 1 0.0007
301 INJECTION SITE HYPOAESTHESIA 1 0.0007
302 BACTERIAL INFECTION 13 0.0007
303 BRAIN HERNIATION 2 0.0007
304 SEPTIC SHOCK 29 0.0007
305 ADHESION 1 0.0007
306 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
307 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 36 0.0007
308 HAEMATOCHEZIA 36 0.0007
309 DUODENITIS 2 0.0007
310 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
311 MEAN CELL VOLUME DECREASED 1 0.0006
312 NEPHROGENIC ANAEMIA 3 0.0006
313 COAGULATION TIME PROLONGED 1 0.0006
314 EYELIDS PRURITUS 2 0.0006
315 COUGH 180 0.0006
316 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
317 INHIBITORY DRUG INTERACTION 1 0.0006
318 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
319 BLADDER PAIN 2 0.0006
320 ENTERITIS 4 0.0006
321 RASH VESICULAR 3 0.0006
322 FEBRILE NEUTROPENIA 41 0.0006
323 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
324 EMPHYSEMA 6 0.0006
325 CLOSTRIDIAL INFECTION 2 0.0006
326 BONE MARROW FAILURE 12 0.0006
327 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 42 0.0006
328 MILIARIA 1 0.0006
329 CERVICAL SPINAL STENOSIS 1 0.0006
330 BLOOD CREATININE ABNORMAL 2 0.0006
331 MALAISE 253 0.0006
332 APLASTIC ANAEMIA 3 0.0006
333 FANCONI SYNDROME ACQUIRED 1 0.0006
334 SERUM FERRITIN INCREASED 3 0.0006
335 THROMBOTIC THROMBOCYTOPENIC PURPURA 2 0.0006
336 PNEUMOTHORAX 9 0.0006
337 BLOOD BILIRUBIN INCREASED 15 0.0006
338 MONOCYTE COUNT INCREASED 2 0.0006
339 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
340 ESSENTIAL HYPERTENSION 1 0.0005
341 ACUTE KIDNEY INJURY 83 0.0005
342 CYSTIC FIBROSIS 3 0.0005
343 GASTRIC ULCER HAEMORRHAGE 3 0.0005
344 COAGULOPATHY 9 0.0005
345 DEFORMITY 5 0.0005
346 RESPIRATORY FAILURE 39 0.0005
347 EYE INFECTION 6 0.0005
348 HUMAN HERPESVIRUS 6 INFECTION 1 0.0005
349 CATHETER SITE INFECTION 2 0.0005
350 BLOOD BICARBONATE DECREASED 1 0.0005
351 CARDIAC VALVE DISEASE 3 0.0005
352 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
353 HAEMOLYSIS 4 0.0005
354 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
355 PULMONARY HAEMORRHAGE 4 0.0005
356 APLASIA 1 0.0005
357 HYPERAEMIA 1 0.0005
358 CANDIDIASIS 2 0.0005
359 FOAMING AT MOUTH 1 0.0005
360 MYASTHENIA GRAVIS 4 0.0005
361 SEPSIS 55 0.0005
362 THERAPEUTIC PRODUCT EFFECT DECREASED 22 0.0005
363 ENCEPHALOPATHY 12 0.0005
364 CONJUNCTIVITIS 9 0.0005
365 BODY TEMPERATURE FLUCTUATION 1 0.0005
366 SWELLING OF EYELID 3 0.0005
367 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
368 VOMITING 222 0.0005
369 FOETAL DISTRESS SYNDROME 1 0.0005
370 LUNG NEOPLASM 2 0.0005
371 MEDICAL DEVICE PAIN 1 0.0005
372 HERPES SIMPLEX 3 0.0005
373 SKIN LACERATION 5 0.0005
374 PAIN 282 0.0005
375 TREATMENT FAILURE 38 0.0005
376 ASPERGILLUS INFECTION 3 0.0005
377 CORNEAL DISORDER 1 0.0005
378 LIMB MASS 1 0.0005
379 LUNG INFILTRATION 4 0.0005
380 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
381 RENAL IMPAIRMENT 38 0.0005
382 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
383 FOOT DEFORMITY 5 0.0005
384 LARGE INTESTINAL OBSTRUCTION 1 0.0004
385 JOINT RANGE OF MOTION DECREASED 6 0.0004
386 MENINGITIS ASEPTIC 2 0.0004
387 PAPILLOEDEMA 2 0.0004
388 NEUTROPHIL COUNT DECREASED 18 0.0004
389 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
390 TACHYPNOEA 6 0.0004
391 C-REACTIVE PROTEIN INCREASED 16 0.0004
392 CYTOMEGALOVIRUS COLITIS 1 0.0004
393 HYPOMAGNESAEMIA 6 0.0004
394 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
395 NEPHROPATHY 4 0.0004
396 DYSPEPSIA 42 0.0004
397 PLATELET COUNT DECREASED 45 0.0004
398 ATAXIA 5 0.0004
399 BLOOD UREA INCREASED 7 0.0004
400 KIDNEY TRANSPLANT REJECTION 2 0.0004
401 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
402 MOUTH HAEMORRHAGE 3 0.0004
403 GLOMERULONEPHRITIS 1 0.0004
404 DERMAL CYST 1 0.0004
405 INFREQUENT BOWEL MOVEMENTS 1 0.0004
406 HYPERAMMONAEMIA 2 0.0004
407 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
408 EOSINOPHILIA 7 0.0004
409 EYELID IRRITATION 1 0.0004
410 HYPOAESTHESIA ORAL 6 0.0004
411 BRAIN ABSCESS 1 0.0004
412 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
413 TOXIC ENCEPHALOPATHY 2 0.0004
414 DERMATOMYOSITIS 1 0.0004
415 ABDOMINAL INFECTION 1 0.0004
416 CANCER PAIN 1 0.0004
417 MUCORMYCOSIS 1 0.0004
418 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
419 LEARNING DISABILITY 2 0.0004
420 BLOOD SODIUM INCREASED 1 0.0004
421 ERYTHEMA OF EYELID 2 0.0004
422 BLOOD PHOSPHORUS INCREASED 1 0.0004
423 ACUTE RESPIRATORY FAILURE 7 0.0004
424 DRUG LEVEL INCREASED 6 0.0004
425 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
426 EOSINOPHIL COUNT INCREASED 3 0.0004
427 STREPTOCOCCAL INFECTION 2 0.0004
428 ANAL HAEMORRHAGE 1 0.0004
429 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
430 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
431 DYSPNOEA 200 0.0004
432 HAEMATOCRIT DECREASED 7 0.0004
433 ANURIA 3 0.0003
434 HYPOKALAEMIA 16 0.0003
435 STOMATITIS 21 0.0003
436 EYELID OEDEMA 4 0.0003
437 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
438 TUMOUR LYSIS SYNDROME 3 0.0003
439 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
440 RESPIRATORY RATE INCREASED 3 0.0003
441 BACTERAEMIA 4 0.0003
442 INFUSION SITE REACTION 1 0.0003
443 METABOLIC ENCEPHALOPATHY 1 0.0003
444 CHEST X-RAY ABNORMAL 1 0.0003
445 BRAIN DEATH 1 0.0003
446 CHOLANGITIS 2 0.0003
447 PHARYNGITIS 4 0.0003
448 ACUTE MYELOID LEUKAEMIA 5 0.0003
449 EYE INFLAMMATION 3 0.0003
450 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
451 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
452 LIVER ABSCESS 1 0.0003
453 FACET JOINT SYNDROME 1 0.0003
454 HYPOVENTILATION 1 0.0003
455 LYMPHOCYTE COUNT INCREASED 1 0.0003
456 RENAL TUBULAR NECROSIS 3 0.0003
457 WHITE BLOOD CELL COUNT DECREASED 33 0.0003
458 ANAEMIA 58 0.0003
459 LISTLESS 1 0.0003
460 PYREXIA 105 0.0003
461 RENAL INJURY 9 0.0003
462 CHRONIC KIDNEY DISEASE 23 0.0003
463 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
464 BRONCHIECTASIS 2 0.0003
465 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
466 CANDIDA INFECTION 5 0.0003
467 BRONCHOPNEUMONIA 1 0.0003
468 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
469 LEFT VENTRICULAR FAILURE 1 0.0003
470 MULTI-ORGAN FAILURE 5 0.0003
471 THERAPY NON-RESPONDER 13 0.0003
472 BRONCHIOLITIS 1 0.0003
473 PAPULE 2 0.0003
474 LOGORRHOEA 1 0.0003
475 LUNG TRANSPLANT 1 0.0003
476 DRUG ERUPTION 5 0.0003
477 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
478 FIBRIN D DIMER INCREASED 1 0.0003
479 HAEMORRHAGIC DIATHESIS 1 0.0003
480 PARALYSIS 4 0.0003
481 BONE LESION 1 0.0003
482 LEUKOCYTOSIS 5 0.0003
483 DERMATITIS BULLOUS 2 0.0003
484 BLOOD CREATININE INCREASED 18 0.0003
485 END STAGE RENAL DISEASE 5 0.0003
486 AMYLASE INCREASED 1 0.0003
487 CARDIAC DYSFUNCTION 1 0.0003
488 INTERSTITIAL LUNG DISEASE 13 0.0003
489 IMMUNODEFICIENCY 4 0.0003
490 SKIN INFECTION 3 0.0003
491 OCULAR DISCOMFORT 3 0.0003
492 HYDRONEPHROSIS 2 0.0003
493 HYPOCALCAEMIA 5 0.0003
494 ECONOMIC PROBLEM 4 0.0003
495 RHABDOMYOLYSIS 11 0.0003
496 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
497 FACE INJURY 1 0.0003
498 ACIDOSIS 2 0.0003
499 SHOCK 6 0.0003
500 LEUKOPENIA 13 0.0003
501 PERICARDIAL EFFUSION 6 0.0003
502 RESPIRATORY ARREST 7 0.0003
503 DRUG INEFFECTIVE 333 0.0003
504 FURUNCLE 2 0.0003
505 CEREBRAL ATROPHY 1 0.0003
506 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
507 TRANSPLANT REJECTION 2 0.0002
508 SPINAL FRACTURE 5 0.0002
509 BLEPHARITIS 1 0.0002
510 HYPERGLYCAEMIA 9 0.0002
511 RHEUMATOID ARTHRITIS 28 0.0002
512 DECUBITUS ULCER 2 0.0002
513 RED BLOOD CELL COUNT DECREASED 7 0.0002
514 ABNORMAL FAECES 2 0.0002
515 CARDIOMEGALY 3 0.0002
516 ESCHERICHIA INFECTION 2 0.0002
517 AORTIC DISSECTION 1 0.0002
518 GASTROINTESTINAL PERFORATION 1 0.0002
519 CARDIO-RESPIRATORY ARREST 10 0.0002
520 ABSCESS LIMB 1 0.0002
521 CARDIAC FAILURE CHRONIC 1 0.0002
522 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
523 ANAPHYLACTIC SHOCK 6 0.0002
524 HORDEOLUM 1 0.0002
525 URINE OUTPUT DECREASED 2 0.0002
526 SPINAL OSTEOARTHRITIS 2 0.0002
527 HAEMORRHAGIC ANAEMIA 1 0.0002
528 GINGIVAL SWELLING 1 0.0002
529 BLOOD PRESSURE DECREASED 15 0.0002
530 LIVER DISORDER 10 0.0002
531 CARDIOTOXICITY 2 0.0002
532 ILEUS PARALYTIC 1 0.0002
533 GASTROINTESTINAL INFECTION 2 0.0002
534 DRUG-INDUCED LIVER INJURY 7 0.0002
535 PANCREATITIS ACUTE 5 0.0002
536 MYELOSUPPRESSION 8 0.0002
537 OPTIC NEURITIS 2 0.0002
538 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
539 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
540 STAPHYLOCOCCAL INFECTION 7 0.0002
541 LYMPHOPENIA 3 0.0002
542 LEUKAEMIA 2 0.0002
543 RENAL FAILURE 28 0.0002
544 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
545 CARDIAC TAMPONADE 1 0.0002
546 SINUS BRADYCARDIA 2 0.0002
547 THROMBOCYTOPENIA 23 0.0002
548 ERYTHEMA 42 0.0002
549 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
550 BREATH SOUNDS ABNORMAL 1 0.0002
551 MUCOUS STOOLS 1 0.0002
552 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
553 HYPERNATRAEMIA 1 0.0002
554 FULL BLOOD COUNT DECREASED 4 0.0002
555 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
556 DRUG LEVEL DECREASED 2 0.0002
557 SUBARACHNOID HAEMORRHAGE 2 0.0002
558 FEMORAL NECK FRACTURE 1 0.0002
559 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
560 CEREBRAL ISCHAEMIA 1 0.0002
561 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
562 ABDOMINAL PAIN 45 0.0002
563 PERITONITIS 4 0.0002
564 RASH GENERALISED 5 0.0002
565 HYPERBILIRUBINAEMIA 2 0.0002
566 HERPES ZOSTER 11 0.0002
567 PREMATURE DELIVERY 3 0.0002
568 EAR INFECTION 5 0.0002
569 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
570 FOOD POISONING 1 0.0002
571 ANAL ABSCESS 1 0.0002
572 GINGIVITIS 1 0.0002
573 DECREASED ACTIVITY 2 0.0002
574 CHEILITIS 1 0.0002
575 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
576 CONSTIPATION 40 0.0002
577 WEIGHT DECREASED 51 0.0002
578 JAW DISORDER 1 0.0002
579 JOINT SWELLING 22 0.0002
580 TRANSAMINASES INCREASED 4 0.0002
581 MALNUTRITION 2 0.0002
582 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
583 OXYGEN SATURATION DECREASED 10 0.0002
584 EYE PAIN 10 0.0002
585 HYPERVENTILATION 1 0.0002
586 VASCULITIS 2 0.0002
587 HYPOVOLAEMIA 1 0.0002
588 HYPERTRIGLYCERIDAEMIA 1 0.0002
589 BRADYKINESIA 1 0.0002
590 COVID-19 PNEUMONIA 2 0.0002
591 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
592 OFF LABEL USE 146 0.0002
593 PLEURAL EFFUSION 10 0.0002
594 NO THERAPEUTIC RESPONSE 2 0.0002
595 CEREBRAL INFARCTION 4 0.0002
596 LIVER INJURY 4 0.0002
597 GENERALISED OEDEMA 2 0.0002
598 HEPATIC ENZYME INCREASED 11 0.0002
599 ILEUS 2 0.0002
600 SECRETION DISCHARGE 2 0.0002
601 HEPATIC CIRRHOSIS 3 0.0002
602 INFUSION SITE SWELLING 1 0.0002
603 PROTEINURIA 3 0.0002
604 METABOLIC ACIDOSIS 5 0.0002
605 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
606 PLATELET COUNT INCREASED 2 0.0002
607 ANHEDONIA 4 0.0002
608 PULMONARY CONGESTION 2 0.0002
609 CARDIAC FAILURE ACUTE 1 0.0001
610 EYE HAEMORRHAGE 2 0.0001
611 URINARY RETENTION 5 0.0001
612 MENINGITIS 1 0.0001
613 BREAST MASS 1 0.0001
614 EYE MOVEMENT DISORDER 1 0.0001
615 ECCHYMOSIS 1 0.0001
616 MENTAL STATUS CHANGES 4 0.0001
617 LARGE INTESTINE PERFORATION 1 0.0001
618 HYPERTRANSAMINASAEMIA 1 0.0001
619 FORMICATION 1 0.0001
620 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
621 EXTRASYSTOLES 1 0.0001
622 DERMATITIS 3 0.0001
623 BLOOD TEST ABNORMAL 2 0.0001
624 HYPOXIA 5 0.0001
625 DUODENAL ULCER 1 0.0001
626 RENAL FAILURE ACUTE 6 0.0001
627 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
628 CARDIAC FAILURE 11 0.0001
629 MAJOR DEPRESSION 1 0.0001
630 MELAENA 3 0.0001
631 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
632 HYPOPHOSPHATAEMIA 1 0.0001
633 ARTHROPOD BITE 1 0.0001
634 RASH MACULO-PAPULAR 3 0.0001
635 CONDITION AGGRAVATED 41 0.0001
636 HEPATOTOXICITY 3 0.0001
637 DUODENAL ULCER PERFORATION 1 0.0001
638 RESPIRATORY DISORDER 4 0.0001
639 CARDIAC ARREST 11 0.0001
640 BLOOD POTASSIUM DECREASED 4 0.0001
641 LACRIMATION INCREASED 4 0.0001
642 NEUTROPENIA 18 0.0001
643 HAEMODYNAMIC INSTABILITY 1 0.0001
644 HYPERTHERMIA 1 0.0001
645 DRUG EFFECT DECREASED 7 0.0001
646 DEVICE RELATED INFECTION 2 0.0001
647 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
648 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
649 APHTHOUS ULCER 1 0.0001
650 LUNG INFECTION 2 0.0001
651 EJECTION FRACTION DECREASED 2 0.0001
652 APNOEA 1 0.0001
653 NERVOUS SYSTEM DISORDER 4 0.0001
654 HAEMORRHAGIC STROKE 1 0.0001
655 GASTROINTESTINAL INFLAMMATION 1 0.0001
656 MULTIPLE ALLERGIES 1 0.0001
657 OCULAR HYPERAEMIA 6 0.0001
658 LOW BIRTH WEIGHT BABY 1 0.0001
659 GINGIVAL PAIN 1 0.0001
660 PANCYTOPENIA 7 0.0001
661 EYE DISORDER 4 0.0001
662 EYE IRRITATION 7 0.0001
663 DRY EYE 6 0.0001
664 ATRIAL SEPTAL DEFECT 1 0.0001
665 EYE PRURITUS 4 0.0001
666 CATARACT 7 0.0001
667 CIRCULATORY COLLAPSE 2 0.0001
668 HAEMOGLOBIN DECREASED 12 0.0001
669 DELIRIUM 4 0.0001
670 NEOPLASM PROGRESSION 4 0.0001
671 MUCOSAL INFLAMMATION 3 0.0001
672 LYMPHOCYTE COUNT DECREASED 2 0.0001
673 PULMONARY OEDEMA 5 0.0001
674 HAEMOLYTIC ANAEMIA 1 0.0001
675 JAUNDICE 3 0.0001
676 DEVELOPMENTAL DELAY 1 0.0001
677 GASTROENTERITIS VIRAL 2 0.0001
678 PNEUMONITIS 3 0.0001
679 LIP DRY 1 0.0001
680 BRAIN NEOPLASM 1 0.0001
681 INCREASED TENDENCY TO BRUISE 1 0.0001
682 EYE SWELLING 4 0.0001
683 NAUSEA 85 0.0001
684 RENAL DISORDER 5 0.0001
685 ERYTHEMA MULTIFORME 1 0.0001
686 DYSARTHRIA 4 0.0001
687 ARTERIOSCLEROSIS 1 0.0001
688 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
689 ARRHYTHMIA 5 0.0001
690 SLEEP APNOEA SYNDROME 2 0.0001
691 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
692 HYPERTENSION 22 0.0001
693 INFECTION 15 0.0001
694 ATELECTASIS 1 0.0001
695 PRESCRIBED OVERDOSE 2 0.0001
696 HAEMORRHOIDS 2 0.0001
697 ORAL HERPES 2 0.0001
698 ASCITES 3 0.0001
699 ACUTE MYOCARDIAL INFARCTION 3 0.0001
700 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
701 HYPOTONIA 1 0.0001
702 CYTOKINE RELEASE SYNDROME 2 0.0001
703 HEPATIC FAILURE 3 0.0001
704 EUPHORIC MOOD 1 0.0001
705 INITIAL INSOMNIA 1 0.0001
706 EAR DISCOMFORT 1 0.0001
707 HELICOBACTER INFECTION 1 0.0001
708 EYE DISCHARGE 1 0.0001
709 FOLLICULITIS 1 0.0001
710 SKIN EXFOLIATION 8 0.0001
711 JOINT DISLOCATION 1 0.0001
712 FULL BLOOD COUNT ABNORMAL 1 0.0001
713 DIARRHOEA 61 0.0001
714 PRODUCT USE IN UNAPPROVED INDICATION 23 0.0001
715 IMPAIRED HEALING 3 0.0001
716 ASPIRATION 1 0.0001
717 BLOOD GLUCOSE FLUCTUATION 1 0.0001
718 COVID-19 16 0.0001
719 HEART RATE INCREASED 9 0.0001
720 DENTAL CARIES 1 0.0001
721 FUNGAL INFECTION 3 0.0001
722 STEVENS-JOHNSON SYNDROME 2 0.0001
723 MEDICATION ERROR 5 0.0001
724 GLOSSODYNIA 2 0.0001
725 BLISTER 5 0.0001
726 FISTULA 1 0.0001
727 BLOOD CALCIUM DECREASED 1 0.0001
728 HYPONATRAEMIA 5 0.0001
729 DERMATITIS CONTACT 1 0.0001
730 HAEMATURIA 3 0.0001
731 GASTRIC DISORDER 3 0.0001
732 NEPHROLITHIASIS 4 0.0001
733 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
734 ELECTROLYTE IMBALANCE 1 0.0001
735 CAESAREAN SECTION 1 0.0001
736 HEART RATE DECREASED 3 0.0001
737 BLOOD IRON DECREASED 1 0.0001
738 CHOLECYSTITIS 1 0.0001
739 CEREBRAL HAEMORRHAGE 3 0.0001
740 ACCIDENT 1 0.0001
741 HYPERLIPIDAEMIA 1 0.0001
742 RASH ERYTHEMATOUS 4 0.0001
743 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
744 BURSITIS 1 0.0001
745 ADRENAL INSUFFICIENCY 1 0.0001
746 FIBROMYALGIA 2 0.0001
747 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
748 EPISTAXIS 6 0.0001
749 HYPOTENSION 16 0.0001
750 HEADACHE 50 0.0001
751 DERMATITIS ALLERGIC 1 0.0001
752 BRAIN OEDEMA 1 0.0001
753 MUSCLE ATROPHY 1 0.0001
754 INTRAOCULAR PRESSURE INCREASED 1 0.0001
755 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
756 INFUSION SITE PAIN 1 0.0001
757 ANOREXIA 1 0.0001
758 UNRESPONSIVE TO STIMULI 2 0.0001
759 PLASMA CELL MYELOMA 3 0.0001
760 DEAFNESS 2 0.0001
761 ECZEMA 4 0.0001
762 HAND DEFORMITY 1 0.0001
763 IMMUNE SYSTEM DISORDER 1 0.0001
764 ADVERSE REACTION 1 0.0001
765 DEHYDRATION 10 0.0001
766 CARDIAC FAILURE CONGESTIVE 6 0.0001
767 IMPAIRED GASTRIC EMPTYING 1 0.0001
768 AKATHISIA 1 0.0001
769 ACUTE HEPATIC FAILURE 1 0.0001
770 OSTEOPOROSIS 3 0.0001
771 APPLICATION SITE RASH 1 0.0001
772 RESPIRATORY DISTRESS 2 0.0001
773 ROAD TRAFFIC ACCIDENT 3 0.0001
774 DEMENTIA 2 0.0001
775 CARPAL TUNNEL SYNDROME 1 0.0001
776 RASH 31 0.0001
777 BLINDNESS UNILATERAL 1 0.0001
778 HEPATOCELLULAR INJURY 1 0.0001
779 INTENTIONAL DOSE OMISSION 2 0.0001
780 CONVULSION 4 0.0001
781 CARDIOGENIC SHOCK 1 0.0001
782 DRUG INTERACTION 11 0.0001
783 MENTAL DISORDER 3 0.0001
784 FLUID OVERLOAD 1 0.0001
785 GASTROENTERITIS 1 0.0001
786 LABORATORY TEST ABNORMAL 2 0.0001
787 CARDIOMYOPATHY 1 0.0001
788 HAEMORRHAGE INTRACRANIAL 1 0.0001
789 BONE LOSS 1 0.0001
790 PREMATURE BABY 2 0.0001
791 INSURANCE ISSUE 1 0.0001
792 SKIN DISCOLOURATION 3 0.0001
793 SWELLING 6 0.0001
794 BONE DENSITY DECREASED 2 0.0001
795 ABSCESS 1 0.0001
796 MOVEMENT DISORDER 2 0.0001
797 DRUG INTOLERANCE 6 0.0001
798 HYPOGLYCAEMIA 3 0.0001
799 LACTIC ACIDOSIS 2 0.0001
800 BLOOD POTASSIUM INCREASED 1 0.0001
801 PRODUCT DOSE OMISSION 4 0.0001
802 LIP SWELLING 2 0.0001
803 CELLULITIS 3 0.0001
804 TYPE 2 DIABETES MELLITUS 2 0.0001
805 TOXICITY TO VARIOUS AGENTS 10 0.0001
806 FACE OEDEMA 1 0.0001
807 HYPERSENSITIVITY 11 0.0001
808 DISEASE PROGRESSION 7 0.0001
809 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
810 VISION BLURRED 8 0.0001
811 INFLAMMATION 3 0.0001
812 HAEMORRHAGE 6 0.0001
813 PARAESTHESIA 9 0.0001
814 RASH MACULAR 2 0.0001
815 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
816 HYPERKALAEMIA 2 0.0001
817 DERMATITIS ATOPIC 3 0.0001
818 PANCREATITIS 3 0.0001
819 SLEEP DISORDER 4 0.0001
820 BRADYCARDIA 3 0.0001
821 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
822 BACK PAIN 13 0.0001
823 GASTROINTESTINAL DISORDER 5 0.0001
824 ADVERSE DRUG REACTION 5 0.0001
825 RESTLESSNESS 2 0.0001
826 PRURITUS 21 0.0001
827 ANAPHYLACTIC REACTION 3 0.0001
828 AGRANULOCYTOSIS 1 0.0001
829 HEPATIC STEATOSIS 1 0.0001
830 ABDOMINAL PAIN UPPER 11 0.0001
831 BLOOD SODIUM DECREASED 1 0.0001
832 GASTRIC ULCER 1 0.0001
833 NEUROPATHY PERIPHERAL 5 0.0001
834 FEELING JITTERY 1 0.0001
835 CHOLESTASIS 1 0.0001
836 GLAUCOMA 1 0.0001
837 ERUCTATION 1 0.0001
838 EAR PAIN 1 0.0001
839 ATRIAL FIBRILLATION 5 0.0001
840 NASAL CONGESTION 3 0.0001
841 PRODUCT DOSE OMISSION ISSUE 15 0.0001
842 KIDNEY INFECTION 1 0.0001
843 DISORIENTATION 2 0.0001
844 PSORIATIC ARTHROPATHY 2 0.0000
845 BODY TEMPERATURE INCREASED 1 0.0000
846 INJECTION SITE WARMTH 1 0.0000
847 VISUAL IMPAIRMENT 6 0.0000
848 ABDOMINAL DISTENSION 5 0.0000
849 URTICARIA 8 0.0000
850 MOUTH ULCERATION 1 0.0000
851 HALLUCINATION, VISUAL 1 0.0000
852 EATING DISORDER 1 0.0000
853 IRRITABLE BOWEL SYNDROME 1 0.0000
854 HYPOACUSIS 2 0.0000
855 FAECES DISCOLOURED 1 0.0000
856 ALOPECIA 9 0.0000
857 TACHYCARDIA 4 0.0000
858 INFLUENZA 5 0.0000
859 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
860 TINNITUS 2 0.0000
861 SEIZURE 5 0.0000
862 DECREASED APPETITE 10 0.0000
863 BURNING SENSATION 3 0.0000
864 CHILLS 5 0.0000
865 TREMOR 7 0.0000
866 DYSPHAGIA 4 0.0000
867 DISEASE RECURRENCE 2 0.0000
868 DIABETIC KETOACIDOSIS 1 0.0000
869 URINARY TRACT INFECTION 7 0.0000
870 OEDEMA PERIPHERAL 5 0.0000
871 LUNG DISORDER 2 0.0000
872 BRONCHITIS 3 0.0000
873 DYSGEUSIA 3 0.0000
874 AGEUSIA 1 0.0000
875 HYPOAESTHESIA 6 0.0000
876 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
877 DEPRESSION 9 0.0000
878 ABDOMINAL PAIN LOWER 1 0.0000
879 HEPATITIS 1 0.0000
880 SINUSITIS 4 0.0000
881 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
882 JOINT STIFFNESS 1 0.0000
883 GASTRITIS 1 0.0000
884 INSOMNIA 10 0.0000
885 PAIN IN EXTREMITY 11 0.0000
886 THROMBOSIS 3 0.0000
887 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
888 DEATH 32 0.0000
889 DRY MOUTH 3 0.0000
890 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
891 MOOD ALTERED 1 0.0000
892 GAIT DISTURBANCE 7 0.0000
893 ABNORMAL DREAMS 1 0.0000
894 DIVERTICULITIS 1 0.0000
895 FLATULENCE 2 0.0000
896 MUSCULAR WEAKNESS 4 0.0000
897 ANXIETY 10 0.0000
898 BALANCE DISORDER 3 0.0000
899 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
900 LIVER FUNCTION TEST ABNORMAL 1 0.0000
901 BONE PAIN 2 0.0000
902 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
903 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
904 EMOTIONAL DISTRESS 4 0.0000
905 CORONARY ARTERY DISEASE 1 0.0000
906 ILL-DEFINED DISORDER 2 0.0000
907 VERTIGO 2 0.0000
908 EXPOSURE DURING PREGNANCY 2 0.0000
909 HEAD INJURY 1 0.0000
910 PULMONARY EMBOLISM 3 0.0000
911 CYSTITIS 1 0.0000
912 HYPOTHYROIDISM 1 0.0000
913 WEIGHT INCREASED 7 0.0000
914 CONTUSION 3 0.0000
915 DEEP VEIN THROMBOSIS 2 0.0000
916 SWELLING FACE 2 0.0000
917 PSORIASIS 4 0.0000
918 CHOLELITHIASIS 1 0.0000
919 FALL 10 0.0000
920 SYNCOPE 3 0.0000
921 DRY SKIN 4 0.0000
922 NEOPLASM MALIGNANT 2 0.0000
923 FATIGUE 23 0.0000
924 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
925 CHEST DISCOMFORT 3 0.0000
926 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
927 ASTHENIA 11 0.0000
928 MEMORY IMPAIRMENT 4 0.0000
929 INJURY 2 0.0000
930 THERAPY INTERRUPTED 2 0.0000
931 SKIN BURNING SENSATION 2 0.0000
932 CRYING 1 0.0000
933 DYSURIA 1 0.0000
934 INJECTION SITE MASS 1 0.0000
935 PRODUCT USE ISSUE 5 0.0000
936 DYSPNOEA EXERTIONAL 1 0.0000
937 HALLUCINATION 2 0.0000
938 HOT FLUSH 2 0.0000
939 UNEVALUABLE EVENT 2 0.0000
940 DIZZINESS 13 0.0000
941 ABORTION SPONTANEOUS 1 0.0000
942 SOMNOLENCE 5 0.0000
943 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
944 DYSKINESIA 1 0.0000
945 BLINDNESS 1 0.0000
946 COMPLETED SUICIDE 2 0.0000
947 CEREBROVASCULAR ACCIDENT 4 0.0000
948 LOSS OF CONSCIOUSNESS 3 0.0000
949 HYPERHIDROSIS 3 0.0000
950 DEVICE DISLOCATION 1 0.0000
951 NO ADVERSE EVENT 4 0.0000
952 INCORRECT DOSE ADMINISTERED 5 0.0000
953 ARTHRALGIA 9 0.0000
954 BLOOD CHOLESTEROL INCREASED 1 0.0000
955 COGNITIVE DISORDER 1 0.0000
956 CARDIAC DISORDER 2 0.0000
957 BLOOD GLUCOSE INCREASED 4 0.0000
958 COMA 1 0.0000
959 FLUSHING 2 0.0000
960 FLUID RETENTION 1 0.0000
961 HOSPITALISATION 3 0.0000
962 DEPRESSED MOOD 1 0.0000
963 DRUG DEPENDENCE 3 0.0000
964 ABDOMINAL DISCOMFORT 3 0.0000
965 LETHARGY 1 0.0000
966 MUSCLE SPASMS 3 0.0000
967 FEELING HOT 1 0.0000
968 NASOPHARYNGITIS 3 0.0000
969 AMNESIA 1 0.0000
970 INJECTION SITE PRURITUS 1 0.0000
971 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
972 INJECTION SITE REACTION 1 0.0000
973 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
974 MOBILITY DECREASED 1 0.0000
975 OVERDOSE 3 0.0000
976 DIABETES MELLITUS 1 0.0000
977 BLOOD PRESSURE INCREASED 2 0.0000
978 INJECTION SITE SWELLING 1 0.0000
979 PERIPHERAL SWELLING 2 0.0000
980 INJECTION SITE BRUISING 1 0.0000
981 DRUG DOSE OMISSION 2 0.0000
982 DRUG ABUSE 1 0.0000
983 INTENTIONAL PRODUCT MISUSE 1 0.0000
984 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
985 BREAST CANCER 1 0.0000
986 ILLNESS 1 0.0000
987 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
988 INJECTION SITE ERYTHEMA 1 0.0000
989 FEELING ABNORMAL 1 0.0000
990 INJECTION SITE PAIN 1 0.0000